Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: Effects on withdrawal symptoms and taper outcome

Psychopharmacology

Volumn 141, Issue 1, 1999, Pages 1-5

  Rickels, K ^a   Schweizer, E ^a   Garcia Espana F ^a   Case, G ^a   DeMartinis, N ^a   Greenblatt, D ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Anxiety disorders; Benzodiazepine anxiolytics; Benzodiazepine discontinuation; Substance withdrawal syndrome; Trazodone; Valproate

Indexed keywords

ALPRAZOLAM; DIAZEPAM; LORAZEPAM; TRAZODONE; VALPROIC ACID;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WITHDRAWAL SYNDROME; XEROSTOMIA;

ADULT; AGED; ANTI-ANXIETY AGENTS; ANTIMANIC AGENTS; BENZODIAZEPINES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); SUBSTANCE WITHDRAWAL SYNDROME; TRAZODONE; VALPROIC ACID;

EID: 0032909592     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050798     Document Type: Article

References (23)

1. Anderson GD, Gidal BE, Kantor ED, Wilensky AJ (1994) Loraepam-valproate interaction: studies in normal subjects and isolated perfused rat liver. Epilepsia 35:221-225
2. Ansseau M, De Roeck J (1993) Trazodone in benzodiazepine dependence. J Clin Psychiatry 54:189-191
3. Apelt S, Emrich HM (1990) Sodium valproate in benzodiazepine withdrawal. Am J Psychiatry 147:950-951
4. Bolanos JP, Medina JM (1993) Evidence of stimulation of the gamma-aminobutyric acid shunt by valproate and E-delta 2-valproate in neonatal rat brain. Mol Pharmacol 43:487-490
5. Concas A, Mascia MP, Sanna E, Santoro G, Serra M, Biggio G (1991) "In vivo" administration of valproate decreases t-[35 S] butylbicyclophosphorothionate binding in the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 343:296-300
6. Covi L, Lipman RS, Pattison JH, Derogatis LR, Uhlenhuth EH (1973) Length of treatment with anxiolytic sedatives and response to their sudden withdrawal. Acta Psychiatr Scand 49:51-64
7. Goodman WK, Charney DS, Price LH, Woods SW, Heninger GR (1986) Ineffectiveness of clonidine in the treatment of the ben" zodiazepine withdrawal syndrome: report of three cases. Am J Psychiatry 143:900-903
8. Greenblatt DJ, Franke K, Shader RI (1978) Analysis of lorazepam and its glucuronide metabolite by electro-capture gas-liquid chromatography: use in pharmacokinetic studies of lorazepam. J Chromatogr 146:311-320
9. Greenblatt DJ, Ochs HR, Lloyd BL (1980) Entry of diazepam and its major metabolite into cerebrospinal fluid. Psychopharmacology 70:89-93
10. Greenblatt DJ, Divoll M, Shader RI (1983) Automated gas Chromatographic determination of plasma alprazolam concentrations. J Clin Psychopharmacol 3:366-368
11. Keck PE, McElroy SL, Friedman LM (1992) Valproate and carbamazepine in the treatment of panic and post-traumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes. J Clin Psychopharmacol 12[1 Suppl]:36S-41S
12. Lader M, Olajide D (1987) A comparison of buspirone and placebo in relieving benzodiazepine withdrawal symptoms. J Clin Psychopharmacol 7:11-15
13. Leiderman DB, Balish M, Bromfield EB, Theodore WH (1991) Effect of valproate on human cerebral glucose metabolism. Epilepsia 32:417-422
14. Loscher W (1989) Valproate enhances GABA turnover in the substantia nigra. Brain Res 501:198-203
15. MacDonald RL, Kelly KM (1993) Antiepileptic drug mechanisms of action. Epilepsia 34 [Suppl] 5:1S-8S
16. Rickels K, Schweizer E, Case WG, Greenblatt DJ (1990) Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation. Arch Gen Psychiatry 47:899-907
17. Rickels K, Downing R, Schweizer E, Hassman H (1993) Antidepressants for the treatment of generalized anxiety disorder: a placebo-controlled comparison of imipramine, trazodone and diazepam. Arch Gen Psychiatry 50:884-895
18. SAS 6.03 (1987) Statistical Analysis Systems. SAS Institute Cary, N.C.
19. Schweizer E, Rickels K (1986) Failure of buspirone to manage benzodiazepine withdrawal. Am J Psychiatry 143:1590-1592
20. Schweizer E, Rickels K, Case WG, Greenblatt DJ (1991) Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Effects on withdrawal severity and outcome. Arch Gen Psychiatry 48:448-452
21. Schweizer E, Case, WG, García-España F, Greenblatt DJ, Rickels K (1995) Progesterone co-administration in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal severity and taper outcome. Psychopharmacology 117:424-429
22. Tyrer P, Rutherford D, Huggett T (1981) Benzodiazepine withdrawal symptoms and propranolol. Lancet 1:520-522
23. Zona C, Avoli M (1990) Effects induced by the antiepileptic drug valproic acid upon the ionic currents recorded in rat neocortical neurons in cell culture. Exp Brain Res 81:313-317